Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Copper Complexes as Antitumor Agents:In vitroandIn vivoEvidence
Lucía M. Balsa, Enrique J. Baran, Ignácio E. León
Current Medicinal Chemistry (2021) Vol. 30, Iss. 5, pp. 510-557
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Advances in thiosemicarbazone metal complexes as anti-lung cancer agents
Xianguang Bai, Yunyun Zheng, Jinxu Qi
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 42
Medicinal applications of vanadium complexes with Schiff bases
Kulsum Hashmi, Satya Satya, Sakshi Gupta, et al.
Journal of Trace Elements in Medicine and Biology (2023) Vol. 79, pp. 127245-127245
Closed Access | Times Cited: 31
Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer
Xiangdong Liu, Bo Luo, Xinhong Wu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189013-189013
Closed Access | Times Cited: 28
Promising Dual Anticancer and Antimetastatic Action by a Cu(II) Complex Derived from Acylhydrazone on Human Osteosarcoma Models
Lucía Santa Maria de la Parra, Adolfo I. B. Romo, Joaquín Rodríguez‐López, et al.
Inorganic Chemistry (2024) Vol. 63, Iss. 11, pp. 4925-4938
Closed Access | Times Cited: 14
Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production
Lyudmila V. Bel’skaya, Elena I. Dyachenko
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4646-4687
Open Access | Times Cited: 11
The Importance of Being Casiopeina as Polypharmacologycal Profile (Mixed Chelate–Copper (II) Complexes and Their In Vitro and In Vivo Activities)
Zenayda Aguilar-Jiménez, Adrián Espinoza-Guillén, Karen Reséndiz-Acevedo, et al.
Inorganics (2023) Vol. 11, Iss. 10, pp. 394-394
Open Access | Times Cited: 21
Recently Reported Biological Activities and Action Targets of Pt(II)- and Cu(II)-Based Complexes
Cristhian Eduardo Maciel-Flores, Juan Antonio Lozano-Ãlvarez, Egla Yareth Bivián-Castro
Molecules (2024) Vol. 29, Iss. 5, pp. 1066-1066
Open Access | Times Cited: 7
An 8-aminoquinoline-naphthyl copper complex causes apoptotic cell death by modulating the expression of apoptotic regulatory proteins in breast cancer cells.
Nonzuzo Myeza, Cathy Slabber, Orde Q. Munro, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176764-176764
Open Access | Times Cited: 7
Assessment of Mononuclear/Dinuclear copper acylhydrazone complexes for lung cancer treatment
YouRu Wu, D. Christine Wu, Jianfeng Lan, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107122-107122
Closed Access | Times Cited: 6
Novel mono-, bi-, tri- and tetra-nuclear copper complexes that inhibit tumor growth through apoptosis and anti-angiogenesis
Xiaojun Wang, Minghui Zhu, Shanhe Li, et al.
Journal of Inorganic Biochemistry (2023) Vol. 250, pp. 112403-112403
Closed Access | Times Cited: 15
Finding New Molecular Targets of Two Copper(II)-Hydrazone Complexes on Triple-Negative Breast Cancer Cells Using Mass-Spectrometry-Based Quantitative Proteomics
Lucía M. Balsa, María R. Rodríguez, Verónica Ferraresi-Curotto, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7531-7531
Open Access | Times Cited: 13
Transition metal complexes: a new generation of anticancer drugs
Ignácio E. León
Future Medicinal Chemistry (2024) Vol. 16, Iss. 17, pp. 1727-1730
Closed Access | Times Cited: 5
Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application
Murshid Imam, Jiale Ji, Zhijie Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Antiproliferative activity of a series of copper(II) complexes derived from a furan-containing N-acylhydrazone: monomers, dimers, charge status, and cell mechanistic studies on triple negative breast cancer cells
Olivia Espindola-Moreno, Fagner da Silva Moura, Lucía Santa Maria de la Parra, et al.
Dalton Transactions (2025)
Closed Access
Current state of research on copper complexes in the treatment of breast cancer
Kui Hu, Jingna Guo, Jiemin Zeng, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm
Anahita Beigi, Seyed Morteza Naghib, Amir Matini, et al.
Current Gene Therapy (2024) Vol. 25, Iss. 2, pp. 92-112
Closed Access | Times Cited: 3
Copper(II) complexes containing hydrazone and bipyridine/phenanthroline ligands for anticancer application against breast cancer cells
Dorothy Priyanka Dorairaj, Prashant Kumar, Haritha Rajasekaran, et al.
Journal of Inorganic Biochemistry (2024) Vol. 262, pp. 112759-112759
Closed Access | Times Cited: 3
Structural and spectroscopic studies related to vanadium chemistry and biochemistry
Enrique J. Baran
Coordination Chemistry Reviews (2023) Vol. 502, pp. 215549-215549
Closed Access | Times Cited: 8
Bioinorganic Chemistry of Copper: From Biochemistry to Pharmacology
Ana Maria da Costa Ferreira, Christelle Hureau, Gianella Facchin
Inorganics (2024) Vol. 12, Iss. 4, pp. 97-97
Open Access | Times Cited: 2
Structural elucidation of a new binuclear copper(II)/phenanthroline/2-(2,4-dihydroxybenzoyl)benzoate complex by synchrotron radiation, DNA interaction and cytotoxicity against tumor cells
J. M. Montilla-Suárez, Aline Loures dos Santos, Bianca de Oliveira Araújo, et al.
Inorganic Chemistry Communications (2024) Vol. 167, pp. 112670-112670
Closed Access | Times Cited: 2
A novel heteroleptic Cu(II)-phenanthroline-UDCA complex as lipoxygenase inhibitor and ER-stress inducer in cancer cell lines
Sebastiano Masuri, Lukáš Moráň, Tereza Vesselá, et al.
Journal of Inorganic Biochemistry (2023) Vol. 246, pp. 112301-112301
Open Access | Times Cited: 6
Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models
Lucía M. Balsa, Luisina M. Solernó, María R. Rodríguez, et al.
Chemico-Biological Interactions (2023) Vol. 384, pp. 110685-110685
Closed Access | Times Cited: 6
Copper(ii) complexes of a furan-containing aroylhydrazonic ligand: syntheses, structural studies, solution chemistry and interaction with HSA
Fagner da Silva Moura, Ygor S. Sobrinho, Carolina Stellet, et al.
Dalton Transactions (2023) Vol. 52, Iss. 47, pp. 17731-17746
Closed Access | Times Cited: 5
Vanadocene-functionalized mesoporous silica nanoparticles: platforms for the development of theranostic materials against breast cancer
Michael Aondona Iorhemba, Javier Álvarez‐Conde, Diana Díaz‐García, et al.
Biomedical Materials (2024) Vol. 19, Iss. 3, pp. 035005-035005
Open Access | Times Cited: 1
Elucidating the crystal structures of heteronuclear salen complexes CuL-CdX2 with experimental and computational methods
Hadi Kargar, Mehdi Fallah‐Mehrjardi, Ersin Acar, et al.
Journal of Molecular Structure (2024) Vol. 1318, pp. 139224-139224
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top